Press releases appear below, filter by date.
Novartis, Camurus, Pfizer and Boehringer Ingelheim have been named in advertisements for breaches of the ABPI Code
LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code
GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY
New PMCPA Manager - Mr Keval Dabba
2021 Interactive ABPI Code of Practice - Comes into operation 1 July 2021
Consultation on Amendments to the mandatory template for the 2021 ABPI Code
28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies
Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, Boehringer Ingelheim, Vifor Pharma, GlaxoSmithKline and Sintetica named in advertisements for breaches of the ABPI Code
The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 and changes to and impact on the 2019 ABPI Code of Practice for the Pharmaceutical Industry
Updates to prescribing information for centrally approved medicines and other medicines from 1 January 2021
